Quality of oral anticoagulation treatment in real-life practice and factors associated with optimal therapeutic response in elderly patients

被引:0
|
作者
Tiratera, F. [1 ]
Lanti, F. [2 ]
Placido, A. [1 ]
Magrini, A. [3 ]
Pietroiusti, A. [3 ]
机构
[1] Osped Santo Spirito, UOC Med Interna ASL RME, Rome, Italy
[2] Osped Nuovo Regina Margherita ASL RMA, Rome, Italy
[3] Univ TorVergata, Dipartimento Biopatol Med Occupazionale, Rome, Italy
关键词
Elderly patients; Oral anticoagulation therapy; International normalized ratio; Atrial fibrillation;
D O I
暂无
中图分类号
学科分类号
摘要
Introduction. Oral anticoagulation therapy (OAT) is recommended in several cardiovascular disorders and is increasingly used in elderly patients. Obtaining a stable value of International Normalized Ratio (INR) within the target levels may however represent a difficult goal, in this population. Indeed, there is suggestion that out of range INR values are frequently seen in clinical practice. This fact may be associated with serious adverse events such as bleeding and thromboembolic disorders, which may be often fatal in elderly people. Aim of the present study was to evaluate the factors associated with an increased risk of out of range INR levels in this subgroup of patients. Methods. Consecutive patients admitted to the Emergency Department of two Italian Institutions were analyzed within two hours of their admission. Only patients 70 years or older were eligible for the study. Results. 242 patients were enrolled, 151 of whom (62.4%) with abnormal values. When comparing the characteristics of those within or outside the normal range, it appeared that the former had a higher educational level (27% vs 5%) and more frequently a duration of treatment longer than 5 years (62% vs 27%): OR=7.36; 95% C.I. 3.02-17.95; p < 0.0001, and OR=4.29; 95% C.I. 2.46-7.47; p < 0.0001, respectively. Discussion. The majority of patients in this sample of elderly patients seem unable to maintain optimal INR values. The risk seems higher in patients with a low level of education and with less than 5 year OAT.
引用
收藏
页码:105 / 109
页数:5
相关论文
共 50 条
  • [1] Therapeutic or prophylactic anticoagulation is not associated with bleeding events in thrombocytopenic patients-a real-life study
    Jaehn, P.
    Schwarck-Schwarzlose, S.
    Schaefer, O.
    Dammermann, W.
    Ritter, O.
    Deckert, P. M.
    Reinwald, M.
    ONCOLOGY RESEARCH AND TREATMENT, 2022, 45 (SUPPL 2) : 324 - 325
  • [2] Descriptive analysis of the process and quality of oral anticoagulation management in real-life practice in patients with chronic non-valvular atrial fibrillation: the international study of anticoagulation management (ISAM)
    Ansell, Jack
    Hollowell, Jennifer
    Pengo, Vittorio
    Martinez-Brotons, Fernando
    Caro, Jaime
    Drouet, Ludovic
    JOURNAL OF THROMBOSIS AND THROMBOLYSIS, 2007, 23 (02) : 83 - 91
  • [3] Descriptive analysis of the process and quality of oral anticoagulation management in real-life practice in patients with chronic non-valvular atrial fibrillation: the international study of anticoagulation management (ISAM)
    Jack Ansell
    Jennifer Hollowell
    Vittorio Pengo
    Fernando Martinez-Brotons
    Jaime Caro
    Ludovic Drouet
    Journal of Thrombosis and Thrombolysis, 2007, 23 : 83 - 91
  • [4] Comparison of nocturia response to desmopressin treatment in elderly men with and without nocturnal polyuria in real-life practice
    Chen, S. -L.
    Huang, Y. -H.
    Hung, T. -W.
    Ou, Y. -C.
    INTERNATIONAL JOURNAL OF CLINICAL PRACTICE, 2016, 70 (05) : 372 - 379
  • [5] Self-management of oral anticoagulation in elderly patients - Effects on treatment-related Quality of Life
    Siebenhofer, Andrea
    Hemkens, Lars G.
    Rakovac, Ivo
    Spat, Stephan
    Didjurgeit, Ulrike
    THROMBOSIS RESEARCH, 2012, 130 (03) : E60 - E66
  • [6] Genetic polymorphisms to identify patients with an optimal response to tildrakizumab in psoriasis patients from real-life clinical practice
    Butron-Bris, B.
    Llamas-Velasco, M.
    Ovejero-Benito, M. C.
    Santos-Juanes, J.
    Martinez-Lopez, A.
    Ruiz-Villaverde, R.
    Roustan, G.
    Baniandres, O.
    Izu-Belloso, R.
    de la Cueva, P.
    Sahuquillo-Torralba, A.
    Gonzalez-Quesada, A.
    Vilarrasa-Rull, E.
    Pujol-Montcusi, J.
    Garcia-Martinez, J.
    Navares, M.
    Palomar-Moreno, I.
    Novalbos, J.
    Abad-Santos, F.
    Dauden, E.
    de la Fuente, H.
    EXPERIMENTAL DERMATOLOGY, 2024, 33 (08)
  • [7] Real-life experience of quality of life, treatment satisfaction, and adherence in patients receiving oral anticoagulants for atrial fibrillation
    Benzimra, Michael
    Bonnamour, Beatrix
    Duracinsky, Martin
    Lalanne, Christophe
    Aubert, Jean-Pierre
    Chassany, Olivier
    Aubin-Auger, Isabelle
    Mahe, Isabelle
    PATIENT PREFERENCE AND ADHERENCE, 2018, 12 : 79 - 87
  • [8] Adjuvant treatment in elderly cancer patients: a multicenter real-life experience
    Bassanelli, M.
    Ceribelli, A.
    Giannarelli, D.
    Giacinti, S.
    Viterbo, A.
    Siringo, M.
    Poti, G.
    Roberto, M.
    Macrini, S.
    Falcone, R.
    Giuli, A.
    Di Pietro, F. R.
    Aschelter, A. M.
    Marchetti, P.
    ANNALS OF ONCOLOGY, 2017, 28
  • [9] QUALITY OF LIFE OF STROKE PATIENTS AFTER ENDOVASCULAR TREATMENT IN A REAL-LIFE SETTING
    Araujo, A.
    Miranda, A.
    Novo, J.
    Rodrigues, M.
    Castro, S.
    Gregorio, T.
    Veloso, M.
    Barros, P.
    Pinho, J.
    Ribeiro, M.
    INTERNATIONAL JOURNAL OF STROKE, 2021, 16 (2_SUPPL) : 89 - 89
  • [10] Treatment with therapeutic anticoagulation is not associated with immunotherapy response in advanced cancer patients
    Paul Johannet
    Amelia Sawyers
    Nicholas Gulati
    Douglas Donnelly
    Samuel Kozloff
    Yingzhi Qian
    Alfredo Floristan
    Eva Hernando
    Judy Zhong
    Iman Osman
    Journal of Translational Medicine, 19